Document Type
Journal Article
Publication Date
4-17-2018
Journal
Scientific Reports
Volume
8
Issue
1
DOI
10.1038/s41598-018-24274-6
Abstract
Clinicians often hesitate prescribing corticosteroids to treat corticosteroid-responsive conditions in sickle cell disease (SCD) patients because their use can be associated with complications (increased hospital readmission, rebound pain, strokes, avascular necrosis, acute chest syndrome). Consequently, SCD patients may receive suboptimal treatment for corticosteroid-responsive conditions. We conducted a preclinical trial of dissociative (vamorolone) and conventional (prednisolone) corticosteroid compounds to evaluate their effects on nociception phenotype, inflammation, and organ dysfunction in SCD mice. Prednisolone and vamorolone had no significant effects on nociception phenotype or anemia in homozygous mice. Conversely, prednisolone and vamorolone significantly decreased white blood cell counts and hepatic inflammation. Interestingly, the effects of vamorolone were milder than those of prednisolone, as vamorolone yielded less attenuation of hepatic inflammation compared to prednisolone. Compared to controls and heterozygotes, homozygotes had significant liver necrosis, which was significantly exacerbated by prednisolone and vamorolone despite decreased hepatic inflammation. These hepatic histopathologic changes were associated with increases in transaminases and alkaline phosphatase. Together, these results suggest that, even in the setting of decreasing hepatic inflammation, prednisolone and vamorolone were associated with significant hepatic toxicity in SCD mice. These findings raise the possibility that hepatic function deterioration could occur with the use of corticosteroids (conventional and dissociative) in SCD.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
APA Citation
Almeida, L., Damsker, J., Albani, S., Afsar, N., Kamimura, S., Pratt, D., Kleiner, D., Quezado, M., Gordish-Dressman, H., & Quezado, Z. (2018). The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice.. Scientific Reports, 8 (1). http://dx.doi.org/10.1038/s41598-018-24274-6
Peer Reviewed
1
Open Access
1
Comments
Reproduced with permission of Nature Journals. Scientific Reports.